Image of Jamie Bayona

Jaime Bayona, MD, MPH

Lecturer on Global Health and Social Medicine
603-277-0412

Jaime Bayona, MD, MPH is the Founding Director of Socios En Salud Sucursal Peru (SES), a Lima-based organization that has had significant impact on policies for prevention and treatment of drug-resistant tuberculosis (TB) and HIV and provided training and technical assistance around the world.

A leader in international health and social medicine, Dr Bayona is an authority on programmatic approaches to the control of multidrug-resistant TB and a long-time advocate for community-based primary care. He is the author of numerous publications related to TB control and treatment methods and is currently a co-investigator in a multi-institutional grant funded by the US National Institutes of Health to study the epidemiology of multidrug-resistant TB in Lima.

Dr Bayona received his MD in 1986 from The School of Medicine, National University of Trujillo in Peru and his MPH in 1992 from the Joint Center for Public Health Studies, College of Medicine, University of Wales, UK

Dr. Bayona's research focuses on the epidemiology of tuberculosis, multidrug-resistant tuberculosis, extremely drug-resistant tuberculosis, HIV/AIDS, community-based approaches to dealing with public health problems, social responsibility, and public health approaches in global health. He is also working on the performance evaluation of primary health system is several countries.

Extensive drug resistance acquired during treatment of multidrug-resistant tuberculosis.
Authors: Authors: Cegielski JP, Dalton T, Yagui M, Wattanaamornkiet W, Volchenkov GV, Via LE, Van Der Walt M, Tupasi T, Smith SE, Odendaal R, Leimane V, Kvasnovsky C, Kuznetsova T, Kurbatova E, Kummik T, Kuksa L, Kliiman K, Kiryanova EV, Kim H, Kim CK, Kazennyy BY, Jou R, Huang WL, Ershova J, Erokhin VV, Diem L, Contreras C, Cho SN, Chernousova LN, Chen MP, Caoili JC, Bayona J, Akksilp S.
Clin Infect Dis
View full abstract on Pubmed
Concordance of resistance profiles in households of patients with multidrug-resistant tuberculosis.
Authors: Authors: Parr JB, Mitnick CD, Atwood SS, Chalco K, Bayona J, Becerra MC.
Clin Infect Dis
View full abstract on Pubmed
Parasite infection and tuberculosis disease among children: a case-control study.
Authors: Authors: Franke MF, Del Castillo H, Pereda Y, Lecca L, Fuertes J, Cárdenas L, Becerra MC, Bayona J, Murray M.
Am J Trop Med Hyg
View full abstract on Pubmed
Reducing communication delays and improving quality of care with a tuberculosis laboratory information system in resource poor environments: a cluster randomized controlled trial.
Authors: Authors: Blaya JA, Shin SS, Yagui M, Contreras C, Cegielski P, Yale G, Suarez C, Asencios L, Bayona J, Kim J, Fraser HS.
PLoS One
View full abstract on Pubmed
Modifiable factors associated with tuberculosis disease in children: a case-control study.
Authors: Authors: Franke MF, del Castillo H, Pereda Y, Lecca L, Cárdenas L, Fuertes J, Murray MB, Bayona J, Becerra MC.
Pediatr Infect Dis J
View full abstract on Pubmed
Aggressive regimens for multidrug-resistant tuberculosis reduce recurrence.
Authors: Authors: Franke MF, Appleton SC, Mitnick CD, Furin JJ, Bayona J, Chalco K, Shin S, Murray M, Becerra MC.
Clin Infect Dis
View full abstract on Pubmed
Tuberculosis in children exposed at home to multidrug-resistant tuberculosis.
Authors: Authors: Becerra MC, Franke MF, Appleton SC, Joseph JK, Bayona J, Atwood SS, Mitnick CD.
Pediatr Infect Dis J
View full abstract on Pubmed
Aggressive regimens for multidrug-resistant tuberculosis decrease all-cause mortality.
Authors: Authors: Mitnick CD, Franke MF, Rich ML, Alcantara Viru FA, Appleton SC, Atwood SS, Bayona JN, Bonilla CA, Chalco K, Fraser HS, Furin JJ, Guerra D, Hurtado RM, Joseph K, Llaro K, Mestanza L, Mukherjee JS, Muñoz M, Palacios E, Sanchez E, Seung KJ, Shin SS, Sloutsky A, Tolman AW, Becerra MC.
PLoS One
View full abstract on Pubmed
Impact of rapid drug susceptibility testing for tuberculosis: program experience in Lima, Peru.
Authors: Authors: Shin SS, Asencios L, Yagui M, Yale G, Suárez C, Bayona J, Bonilla C, Jave O, Contreras CC, Atwood S, Blaya JA, Ershova J, Cegielski JP.
Int J Tuberc Lung Dis
View full abstract on Pubmed
Prevalence of and risk factors for resistance to second-line drugs in people with multidrug-resistant tuberculosis in eight countries: a prospective cohort study.
Authors: Authors: Dalton T, Cegielski P, Akksilp S, Asencios L, Campos Caoili J, Cho SN, Erokhin VV, Ershova J, Gler MT, Kazennyy BY, Kim HJ, Kliiman K, Kurbatova E, Kvasnovsky C, Leimane V, van der Walt M, Via LE, Volchenkov GV, Yagui MA, Kang H, Akksilp R, Sitti W, Wattanaamornkiet W, Andreevskaya SN, Chernousova LN, Demikhova OV, Larionova EE, Smirnova TG, Vasilieva IA, Vorobyeva AV, Barry CE, Cai Y, Shamputa IC, Bayona J, Contreras C, Bonilla C, Jave O, Brand J, Lancaster J, Odendaal R, Chen MP, Diem L, Metchock B, Tan K, Taylor A, Wolfgang M, Cho E, Eum SY, Kwak HK, Lee J, Lee J, Min S, Degtyareva I, Nemtsova ES, Khorosheva T, Kyryanova EV, Egos G, Perez MT, Tupasi T, Hwang SH, Kim CK, Kim SY, Lee HJ, Kuksa L, Norvaisha I, Skenders G, Sture I, Kummik T, Kuznetsova T, Somova T, Levina K, Pariona G, Yale G, Suarez C, Valencia E, Viiklepp P.
Lancet
View full abstract on Pubmed